Edwards HJ - Search Results

1

Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.

Armant DR, Kilburn BA, Petkova A, Edwin SS, Duniec-Dmuchowski ZM, Edwards HJ, Romero R, Leach RE. Armant DR, et al. Among authors: edwards hj. Development. 2006 Feb;133(4):751-9. doi: 10.1242/dev.02237. Epub 2006 Jan 11. Development. 2006. PMID: 16407398 Free PMC article.

2

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.

Edwards H, Xie C, LaFiura KM, Dombkowski AA, Buck SA, Boerner JL, Taub JW, Matherly LH, Ge Y. Edwards H, et al. Blood. 2009 Sep 24;114(13):2744-52. doi: 10.1182/blood-2008-09-179812. Epub 2009 Jul 28. Blood. 2009. PMID: 19638627 Free PMC article.

3

Peroxisome senescence in human fibroblasts.

Legakis JE, Koepke JI, Jedeszko C, Barlaskar F, Terlecky LJ, Edwards HJ, Walton PA, Terlecky SR. Legakis JE, et al. Among authors: edwards hj. Mol Biol Cell. 2002 Dec;13(12):4243-55. doi: 10.1091/mbc.e02-06-0322. Mol Biol Cell. 2002. PMID: 12475949 Free PMC article.

4

A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.

Knight T, Luedtke D, Edwards H, Taub JW, Ge Y. Knight T, et al. Biochem Pharmacol. 2019 Apr;162:250-261. doi: 10.1016/j.bcp.2019.01.015. Epub 2019 Jan 19. Biochem Pharmacol. 2019. PMID: 30668936 Review.

5

CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action.

Hu C, Xia H, Bai S, Zhao J, Edwards H, Li X, Yang Y, Lyu J, Wang G, Zhan Y, Dong Y, Ge Y. Hu C, et al. J Cell Mol Med. 2020 Jul;24(13):7239-7253. doi: 10.1111/jcmm.15281. Epub 2020 May 27. J Cell Mol Med. 2020. PMID: 32459381 Free PMC article.

6

Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.

Wang G, Chen S, Edwards H, Cui X, Cui L, Ge Y. Wang G, et al. Oncol Rep. 2014 Dec;32(6):2789-94. doi: 10.3892/or.2014.3525. Epub 2014 Oct 3. Oncol Rep. 2014. PMID: 25333301

7

Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.

Su Y, Li X, Ma J, Zhao J, Liu S, Wang G, Edwards H, Taub JW, Lin H, Ge Y. Su Y, et al. Biochem Pharmacol. 2018 Feb;148:13-26. doi: 10.1016/j.bcp.2017.11.022. Epub 2017 Dec 5. Biochem Pharmacol. 2018. PMID: 29208365 Free PMC article.

8

Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.

Caldwell JT, Edwards H, Buck SA, Ge Y, Taub JW. Caldwell JT, et al. Pediatr Blood Cancer. 2014 Oct;61(10):1767-73. doi: 10.1002/pbc.25081. Epub 2014 Jun 24. Pediatr Blood Cancer. 2014. PMID: 24962331 Free PMC article.

9

Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.

Xie C, Edwards H, Lograsso SB, Buck SA, Matherly LH, Taub JW, Ge Y. Xie C, et al. Pediatr Blood Cancer. 2012 Dec 15;59(7):1245-51. doi: 10.1002/pbc.24152. Epub 2012 Apr 5. Pediatr Blood Cancer. 2012. PMID: 22488775 Free PMC article.

10

Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.

Luedtke DA, Su Y, Liu S, Edwards H, Wang Y, Lin H, Taub JW, Ge Y. Luedtke DA, et al. J Cell Mol Med. 2018 Dec;22(12):6099-6111. doi: 10.1111/jcmm.13886. Epub 2018 Sep 14. J Cell Mol Med. 2018. PMID: 30596398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters